Page last updated: 2024-08-24

triazoles and cyclin d1

triazoles has been researched along with cyclin d1 in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (12.00)29.6817
2010's21 (84.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Fang, RY; He, QJ; Lou, YJ; Yang, B1
Murphy, PV; O'Boyle, KM; Zhao, Y; Zhou, Y1
Baselga, J; Bellet, M; Bianchi, G; Campone, M; Dixon, JM; Gardner, H; Greil, R; Jonat, W; Kubista, E; Lane, HA; Manikhas, A; Mayordomo, J; Molloy, B; Phillips, P; Rugo, HS; Semiglazov, V; Steinseifer, J; Stumm, M; Tokaji, E; van Dam, P1
Alfieri, RR; Belletti, S; Bonelli, MA; Bottini, A; Cavazzoni, A; Dowsett, M; Evans, DB; Fox, SB; Fumarola, C; Galetti, M; Gatti, R; Generali, D; Harris, AL; La Monica, S; Martin, LA; Petronini, PG1
Albrecht, JH; Anttila, C; Blomquist, CH; Delvoux, B; Hanse, EA; Mason, JI; Mullany, LK; Romano, A1
Beyer, A; Cai, WY; Elledge, R; Fuqua, S; Hilsenbeck, S; Huang, J; Massarweh, S; Rimawi, M; Sexton, K; Tham, YL; Tsimelzon, A; Weiss, H1
Alinger, B; Berr, F; Di Fazio, P; Fuereder, J; Kiesslich, T; Neureiter, D; Oberdanner, C; Ocker, M; Pichler, M; Wachter, J1
Brown, M; Cuzick, J; Dowsett, M; Howell, A; Landberg, G; Lundgren, K; Pineda, S; Salter, J; Zabaglo, L1
Bane, F; Byrne, C; Conroy, RM; Gaora, PÓ; Hao, Y; Hill, AD; McBryan, J; McIlroy, M; O'Hara, J; Tibbitts, P; Vareslija, D; Young, LS1
Dreyling, M; Granot, G; Levi, I; Mor-Tzuntz, R; Nathan, I; Shpilberg, O; Vazana-Barad, L1
Ford, SJ; Jansson, PJ; Kalinowski, DS; Kovacevic, Z; Lovejoy, DB; Lui, GY; Obeidy, P; Richardson, DR; Sharp, DM; Tselepis, C1
Chang, LS; Chen, CY; Chung, MI; Hsiao, CT; Hsu, CC; Hu, WP; Lee, PH; Lin, YT; Lin, YY; Wang, JJ; Yu, WT1
Abbas, SE; Abdel-Aziz, HA; Abou-Seri, SM; Eladwy, RA; Fares, M; Youssef, MM1
Aberdeen, GW; Albrecht, ED; Dumitrescu, A; Pepe, GJ1
Boer, K; Bondarenko, IM; Crown, JP; Ettl, J; Finn, RS; Fowst, C; Huang, X; Kim, ST; Kulyk, SO; Lang, I; Patel, R; Pinter, T; Randolph, S; Schmidt, M; Shparyk, Y; Slamon, DJ; Thummala, AR; Voytko, NL1
Chinthakindi, PK; Hamid, A; Hussain, A; Khan, I; Koul, S; Majeed, R; Sangwan, PL; Saxena, AK; Sharma, PR1
Bansal, N; Bertino, JR; DiPaola, RS; Mishra, PJ; Stein, M1
Andreeff, M; Davis, RE; Fujimura, T; Ishizawa, J; Kauffman, M; Kazuno, S; Kojima, K; Ma, W; Matsushita, H; Miida, T; Sekihara, K; Shacham, S; Tabe, Y; Ueno, T; Wang, Z; Yamamoto, S1
Ali Alharbi, S; Ananda, H; Baburajeev, CP; Bender, A; Chinnathambi, A; Dhananjaya Mohan, C; Fuchs, JE; Girish, KS; Jagadish, S; Li, F; Rangappa, KS; Rangappa, S; Sethi, G; Sivaraman Siveen, K; Zayed, ME; Zhang, J1
Festuccia, C; Gravina, GL; Kauffman, M; Landesman, Y; Mancini, A; Marampon, F; McCauley, D; Sanita, P; Shacham, S; Ventura, L; Vitale, F1
Aytaç, PS; Çetin-Atalay, R; Durmaz, I; Houston, DR; Tozkoparan, B1
Junyan, P; Shujuan, Y; Shulin, G; Xia, X; Yan, C1
Cheng, SY; Enomoto, K; Meltzer, P; Qi, J; Willingham, MC; Zhao, L; Zhu, X; Zhu, YJ1
Bai, JY; She, C; Xiang, T; Yu, DJ; Zhao, TL; Zhou, XZ1
Dong, G; Du, G; Hu, Q; Lu, C; Martin, EM; Qin, Y; Wang, X; Xia, Y; Zhang, R1

Trials

4 trial(s) available for triazoles and cyclin d1

ArticleYear
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jun-01, Volume: 27, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Cell Proliferation; Chemotherapy, Adjuvant; Class I Phosphatidylinositol 3-Kinases; Cyclin D1; Double-Blind Method; Europe; Everolimus; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Letrozole; Middle Aged; Mutation; Neoadjuvant Therapy; Nitriles; Palpation; Phosphatidylinositol 3-Kinases; Phosphorylation; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Ribosomal Protein S6 Kinases; Sirolimus; Time Factors; Treatment Outcome; Triazoles; United States

2009
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.
    Breast cancer research and treatment, 2011, Volume: 129, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Cell Cycle; Cyclin D1; Estradiol; Female; Fulvestrant; Gefitinib; Humans; Ki-67 Antigen; Male; Mitogen-Activated Protein Kinases; Neoadjuvant Therapy; Nitriles; Oncogene Protein v-akt; Proto-Oncogene Proteins; Quinazolines; Receptors, Estrogen; Receptors, Progesterone; Triazoles

2011
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.
    Breast cancer research : BCR, 2012, Apr-04, Volume: 14, Issue:2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclin D1; Female; Follow-Up Studies; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Ki-67 Antigen; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Tamoxifen; Treatment Outcome; Triazoles

2012
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
    The Lancet. Oncology, 2015, Volume: 16, Issue:1

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p16; Disease-Free Survival; Drug Administration Schedule; Europe; Female; Humans; Intention to Treat Analysis; Letrozole; Middle Aged; Molecular Targeted Therapy; Nitriles; North America; Piperazines; Postmenopause; Proportional Hazards Models; Protein Kinase Inhibitors; Pyridines; Receptor, ErbB-2; Receptors, Estrogen; Republic of Korea; South Africa; Time Factors; Treatment Outcome; Triazoles

2015

Other Studies

21 other study(ies) available for triazoles and cyclin d1

ArticleYear
Contragestazol (DL111-IT) inhibits proliferation of human androgen-independent prostate cancer cell line PC3 in vitro and in vivo.
    Asian journal of andrology, 2005, Volume: 7, Issue:4

    Topics: Androgens; Animals; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 4; Dose-Response Relationship, Drug; Female; G1 Phase; Humans; Immunosuppressive Agents; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Resting Phase, Cell Cycle; Retinoblastoma Protein; Transplantation, Heterologous; Triazoles

2005
Hybrids of 1-deoxynojirimycin and aryl-1,2,3-triazoles and biological studies related to angiogenesis.
    Bioorganic & medicinal chemistry, 2008, Jun-15, Volume: 16, Issue:12

    Topics: 1-Deoxynojirimycin; Aminopeptidases; Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Cattle; Cell Cycle; Cell Line; Cell Movement; Cell Proliferation; Cyclin D1; Endothelial Cells; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Metalloendopeptidases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Stress Fibers; Triazoles

2008
Synergistic activity of letrozole and sorafenib on breast cancer cells.
    Breast cancer research and treatment, 2010, Volume: 124, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Inducing Factor; Aromatase; Aromatase Inhibitors; Benzenesulfonates; Breast Neoplasms; Caspase 7; Caspase 9; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cytochromes c; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Female; Humans; Letrozole; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Niacinamide; Nitriles; Phenylurea Compounds; Phosphoproteins; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proteins; Proto-Oncogene Proteins c-myc; Pyridines; Retinoblastoma Protein; Ribosomal Protein S6 Kinases, 70-kDa; Sorafenib; Testosterone; Time Factors; TOR Serine-Threonine Kinases; Transfection; Triazoles

2010
Cyclin D1 regulates hepatic estrogen and androgen metabolism.
    American journal of physiology. Gastrointestinal and liver physiology, 2010, Volume: 298, Issue:6

    Topics: Androgens; Animals; Aromatase Inhibitors; Cell Line, Tumor; Cyclin D1; Estrogens; Gene Expression Profiling; Gene Expression Regulation; Humans; Letrozole; Liver; Liver Regeneration; Male; Mice; Mice, Inbred BALB C; Nitriles; Triazoles

2010
Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.
    International journal of biological sciences, 2012, Volume: 8, Issue:1

    Topics: Antineoplastic Agents; Benzimidazoles; beta Catenin; Biliary Tract Neoplasms; Cadherins; Cell Line, Tumor; Cell Survival; Clinical Trials as Topic; Cyclin D1; Flavonoids; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Quercetin; RNA, Messenger; Sulfonamides; Triazoles; Vimentin; Wnt Signaling Pathway

2012
AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Jun-15, Volume: 18, Issue:12

    Topics: Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Disease-Free Survival; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Letrozole; MAP Kinase Signaling System; Neoplasm Recurrence, Local; Nitriles; Nuclear Receptor Coactivator 3; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Transcription, Genetic; Trefoil Factor-1; Triazoles; Tumor Suppressor Proteins; Up-Regulation

2012
Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Benzoates; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin D1; Deferasirox; Gene Expression Regulation, Neoplastic; Humans; Iron; Iron Chelating Agents; Lymphoma, Mantle-Cell; Proteasome Endopeptidase Complex; Proteolysis; RNA, Messenger; Triazoles

2013
The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action.
    Molecular pharmacology, 2013, Volume: 83, Issue:1

    Topics: Administration, Oral; Animals; Antigens, CD; Antineoplastic Agents; Apoptosis; Benzoates; Cell Cycle; Cell Line, Tumor; Copper; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Deferasirox; Female; Humans; Iron; Iron Chelating Agents; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neuroectodermal Tumors, Primitive, Peripheral; Protein Serine-Threonine Kinases; Receptors, Transferrin; Small Cell Lung Carcinoma; Transplantation, Heterologous; Triazoles; Zinc

2013
Synthesis, DNA-binding abilities and anticancer activities of triazole-pyrrolo[2,1-c][1,4]benzodiazepines hybrid scaffolds.
    Bioorganic & medicinal chemistry letters, 2013, Dec-15, Volume: 23, Issue:24

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzodiazepines; Cell Line, Tumor; Cyclin D1; DNA; Down-Regulation; G1 Phase Cell Cycle Checkpoints; Humans; Isomerism; Mice; Pyrroles; Triazoles; Up-Regulation

2013
Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
    European journal of medicinal chemistry, 2014, Aug-18, Volume: 83

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Pyrimidines; Triazoles

2014
Placental estrogen suppresses cyclin D1 expression in the nonhuman primate fetal adrenal cortex.
    Endocrinology, 2014, Volume: 155, Issue:12

    Topics: Adrenal Cortex; Animals; Aromatase Inhibitors; Carrier Proteins; Cyclin D1; Cyclin-Dependent Kinases; Dehydroepiandrosterone Sulfate; Estradiol; Estrogens; Female; Fetal Development; Fetal Weight; Hydrocortisone; Ki-67 Antigen; Letrozole; Male; Nitriles; Papio anubis; Placenta; Pregnancy; Triazoles

2014
PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation.
    Molecular carcinogenesis, 2016, Volume: 55, Issue:5

    Topics: Betulinic Acid; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HL-60 Cells; Humans; MCF-7 Cells; Neoplasms; Pentacyclic Triterpenes; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Signal Transduction; Triazoles; Triterpenes

2016
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells.
    Oncotarget, 2015, Jun-20, Volume: 6, Issue:17

    Topics: Adenylate Kinase; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Docetaxel; Drug Resistance, Neoplasm; Enzyme Activation; Epithelial-Mesenchymal Transition; Gene Knockdown Techniques; Humans; Male; Metformin; Neoplasm Invasiveness; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Taxoids; Triazoles; Up-Regulation

2015
Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Acrylates; Active Transport, Cell Nucleus; Antineoplastic Agents; B-Lymphocytes; Cell Line, Tumor; Cyclin D1; DNA-Binding Proteins; Elongation Factor 2 Kinase; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; Humans; Karyopherins; Organelle Biogenesis; Peptide Elongation Factor 1; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-pim-1; Receptors, Cytoplasmic and Nuclear; Ribosomes; Signal Transduction; Transcription Factors; Transcription, Genetic; Triazoles; Tumor Suppressor Protein p53

2015
Development of Novel Triazolo-Thiadiazoles from Heterogeneous "Green" Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors.
    Scientific reports, 2015, Sep-21, Volume: 5

    Topics: Animals; Antineoplastic Agents; Benzofurans; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Movement; Chromones; Cyclin D1; Disease Models, Animal; Dose-Response Relationship, Drug; Female; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Mice; Models, Molecular; Neoplasm Invasiveness; Neovascularization, Pathologic; Poly(ADP-ribose) Polymerases; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor; Structure-Activity Relationship; Survivin; Thiadiazoles; Triazoles

2015
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.
    BMC cancer, 2015, Dec-01, Volume: 15

    Topics: Adult; Analgesics; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Nude; Neoplasm Grading; Oxadiazoles; Prostatic Neoplasms; Survivin; Triazoles; Up-Regulation; Xenograft Model Antitumor Assays

2015
Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins.
    Bioorganic & medicinal chemistry, 2016, Feb-15, Volume: 24, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Cell Line, Tumor; Cyclin D1; Cytoskeletal Proteins; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; HCT116 Cells; Hepatocytes; Humans; Inhibitory Concentration 50; MAP Kinase Kinase Kinase 5; MCF-7 Cells; Molecular Docking Simulation; Nuclear Proteins; Oxidative Stress; Protein Structure, Secondary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship; Signal Transduction; Thiadiazines; Triazoles

2016
The Antitumor Effect of DYC-279 on Human Hepatocellular Carcinoma HepG2 Cells.
    Pharmacology, 2016, Volume: 97, Issue:3-4

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; CDC2 Protein Kinase; Cell Proliferation; Cell Survival; Cyclin B1; Cyclin D1; Cyclin-Dependent Kinases; Cytochromes c; Hep G2 Cells; Humans; Liver Neoplasms; Piperazines; Proto-Oncogene Proteins c-bcl-2; Triazoles

2016
Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Jan-15, Volume: 23, Issue:2

    Topics: Animals; Azepines; Cell Line, Tumor; Cell Proliferation; Chromatin Assembly and Disassembly; Cyclin D1; Cyclin-Dependent Kinase 4; E2F3 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Mice; Proteins; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Rats; Signal Transduction; Thyroid Hormone Receptors beta; Thyroid Neoplasms; Triazoles; Xenograft Model Antitumor Assays

2017
Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma.
    Cellular signalling, 2018, Volume: 42

    Topics: Acetamides; Animals; Apoptosis; Azepines; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; CRISPR-Cas Systems; Cyclin D1; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Mice; Mice, SCID; Nuclear Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Skin Neoplasms; Transcription Factors; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays

2018
Prothioconazole induces cell cycle arrest by up-regulation of EIF4EBP1 in extravillous trophoblast cells.
    Archives of toxicology, 2022, Volume: 96, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line; Cell Movement; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Female; Fungicides, Industrial; Gene Knockdown Techniques; Humans; Triazoles; Trophoblasts; Up-Regulation

2022